Wells Fargo & Company Crispr Therapeutics Ag Transaction History

Wells Fargo & Company

$434 Billion
Q3 2024

A detailed history of Wells Fargo & Company transactions in Crispr Therapeutics Ag stock. As of the latest transaction made, Wells Fargo & Company holds 203,029 shares of CRSP stock, worth $8.44 Million. This represents 0.0% of its overall portfolio holdings.

Number of Shares

203,029

Previous 227,599 10.8%

Holding current value

$8.44 Million

Previous $12.3 Million 22.39%

% of portfolio

0.0%

Previous 0.0%

19 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 13, 2024	SELL	$44.62 - $62.75 $1.1 Million - $1.54 Million	-24,570 Reduced 10.8%	203,029 $9.54 Million
Q2 2024 Aug 13, 2024	BUY	$51.17 - $68.18 $573,359 - $763,956	11,205 Added 5.18%	227,599 $12.3 Million
Q1 2024 May 10, 2024	BUY	$60.67 - $89.12 $2.91 Million - $4.28 Million	47,997 Added 28.5%	216,394 $14.7 Million
Q4 2023 Feb 09, 2024	SELL	$38.62 - $72.18 $1.35 Million - $2.51 Million	-34,841 Reduced 17.14%	168,397 $10.5 Million
Q3 2023 Nov 13, 2023	BUY	$45.39 - $59.0 $126,910 - $164,964	2,796 Added 1.39%	203,238 $9.22 Million
Q2 2023 Aug 15, 2023	SELL	$43.47 - $67.77 $267,470 - $416,988	-6,153 Reduced 2.98%	200,442 $11.3 Million
Q1 2023 May 12, 2023	BUY	$41.0 - $56.12 $2.87 Million - $3.92 Million	69,932 Added 51.17%	206,595 $9.34 Million
Q4 2022 Feb 13, 2023	SELL	$39.19 - $65.67 $117,138 - $196,287	-2,989 Reduced 2.14%	136,663 $5.56 Million
Q3 2022 Nov 14, 2022	BUY	$61.1 - $83.78 $69,959 - $95,928	1,145 Added 0.83%	139,652 $9.13 Million
Q2 2022 Aug 12, 2022	SELL	$43.23 - $73.83 $2.48 Million - $4.24 Million	-57,380 Reduced 29.29%	138,507 $8.42 Million
Q1 2022 May 16, 2022	BUY	$53.19 - $79.24 $196,696 - $293,029	3,698 Added 1.92%	195,887 $12.3 Million
Q4 2021 Feb 14, 2022	SELL	$70.09 - $111.29 $19 Million - $30.1 Million	-270,651 Reduced 58.48%	192,189 $14.6 Million
Q3 2021 Nov 15, 2021	SELL	$110.2 - $156.64 $406,858 - $578,314	-3,692 Reduced 0.79%	462,840 $51.8 Million
Q2 2021 Aug 16, 2021	BUY	$100.84 - $161.89 $8.74 Million - $14 Million	86,690 Added 22.82%	466,532 $75.5 Million
Q1 2021 May 13, 2021	SELL	$110.72 - $210.04 $9.38 Million - $17.8 Million	-84,676 Reduced 18.23%	379,842 $46.3 Million
Q4 2020 Feb 09, 2021	SELL	$79.67 - $173.23 $7.66 Million - $16.7 Million	-96,142 Reduced 17.15%	464,518 $71.1 Million
Q3 2020 Nov 05, 2020	BUY	$78.5 - $100.64 $1.43 Million - $1.84 Million	18,258 Added 3.37%	560,660 $46.9 Million
Q2 2020 Aug 13, 2020	BUY	$38.5 - $76.05 $1.57 Million - $3.11 Million	40,883 Added 8.15%	542,402 $39.9 Million
Q1 2020 May 14, 2020	BUY	$33.68 - $62.53 $16.9 Million - $31.4 Million	501,519 New	501,519 $21.3 Million

Others Institutions Holding CRSP

# of Institutions

485

Shares Held

57.5M

Call Options Held

1.09M

Put Options Held

1.9M

View Full List

About CRISPR Therapeutics AG

Ticker CRSP
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 78,009,296
Market Cap $3.24B
Description
CRISPR Therapeutics AG, a gene editing company, focuses on developing gene-based medicines for serious diseases using its proprietary Clustered Regularly Interspaced Short Palindromic Repeats (CRISPR)/CRISPR-associated protein 9 (Cas9) platform. Its CRISPR/Cas9 is a gene editing technology that allows for precise directed changes to genomic DNA....

More about CRSP

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Wells Fargo & Company, based on Form 13F filings with the SEC.

News

Stay updated on Wells Fargo & Company with notifications on news.

Account

Wells Fargo & Company Crispr Therapeutics Ag Transaction History